E.V. Pel’sHe

E.V. Pel’sHe

Auto-generated profile, based on publicly available information

E.V. Pel’sHe

Moscow Regional Research Institute of Obstetrics and Gynecology

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2023 in Russian Bulletin of Obstetrician-Gynecologist
Verified
Journal Article
Closed access
OTO.V. Trischenkova
O.V. Trischenkova
NZN.V. Zarochentseva
N.V. Zarochentseva
TBT.S. Budykina
T.S. Budykina
LGL.K. Gidzhikhia
L.K. Gidzhikhia
EPE.V. Pel’sHe
E.V. Pel’sHe
IKI.V. Kardava
I.V. Kardava
ЦЕЛЬ ИССЛЕДОВАНИЯ Определить значение генотипирования вируса папилломы человека высокого канцерогенного риска и вакцинации после хирургического лечения в развитии рецидивов интраэпителиальных неоплазий шейки матки. МАТЕРИАЛ И МЕТОДЫ Проведено ретроспективное исследование 105 женщин репродуктивного возраста с цервикальными интраэпителиальными неоплазиями высокой степени, которым проводилось эксцизионное лечение с последующим наблюдением. Проводились клинический осмотр, контроль цитологического исследования мазков с экзо-, эндоцервикса (окрашивание гематоксилином и эозином), ВПЧ-тестирование с генотипированием (14 типов) методом полимеразной цепной реакции в режиме реального времени (AmpliSens), расширенная кольпоскопия через 3, 6, 12 и 24 мес после лечения. РЕЗУЛЬТАТЫ При проведении ВПЧ-типирования до хирургического лечения общий уровень инфицирования составил 88,6% (93/105). ВПЧ 16-го типа (63,8%), 18-го типа (14,3%) и 33-го типа (16,2%) были тремя наиболее распространенными типами. Всем пациенткам с HSIL было проведено хирургическое лечение в объеме эксцизии (n=32, 30,5%) и конизации (n=73, 69,5%) шейки матки. ВПЧ-позитивными через 3 мес остались 41,9% (39 из 93 пациенток). ВПЧ 16-го типа в 49,3% наблюдений вызывал рецидивы (33 из 67), ВПЧ 56-го типа — у 4 пациенток из 6, за ними следовали ВПЧ 18-го типа — у 5 из 15, ВПЧ 33-го типа — у 9 из 17 и ВПЧ 31-го типа — у 4 из 8. Повторное инфицирование после эксцизионного лечения установлено в 13,1% наблюдений. Суммарно у всех наблюдаемых рецидив возник у 49 (46,7%) из 105 пациенток. Через 2 года наблюдения среди 48 вакцинированных рецидив развился у 6 (12,5%) женщин. У невакцинированных пациенток рецидив в течение 2 лет был выявлен в 22,8% наблюдений (13 из 57). При дальнейшем наблюдении до 5 и 7 лет у вакцинированных пациенток рецидив возник еще в 4,2% (2 из 48) и в 2,1% наблюдений (1 из 48) соответственно. В группе невакцинированных пациенток по истечении 5 лет рецидивные формы возникли у 31,6% (18 из 57), а по истечении 7 лет — у 15,8% (9 из 57). ЗАКЛЮЧЕНИЕ Пациентки после лечения HSIL должны наблюдаться длительно. Повышен риск развития рецидива цервикальной интраэпителиальной неоплазии 16, 18, 31, 33 и 56-го генотипов ВПЧ. Проведение ВПЧ-типирования после эксцизионного лечения HSIL является важным анализом в прогнозировании риска развития рецидива.

30 January 2024 in Russian Bulletin of Obstetrician-Gynecologist
Verified
Journal Article
Closed access
EEE.B. Efimkova
E.B. Efimkova
SNS.V. Novikova
S.V. Novikova
EDE.V. Dulaeva
E.V. Dulaeva
MIM.A. Ignat’eVa
M.A. Ignat’eVa
NBN.V. Biryukova
N.V. Biryukova
EPE.V. Pel’sHe
E.V. Pel’sHe
Objective. To analyze obstetric and perinatal outcomes in pregnant women with concomitant respiratory diseases who had acute respiratory infections during gestation. Material and methods. Sixty pregnant women with bronchial asthma of moderately severe course with acute respiratory infection during gestation were examined and delivered. Retrospectively, they were divided into two groups of 30 patients each: Group 1 consisted of patients who had an acute respiratory infection before 16 weeks of gestation, and Group 2 included pregnant women who became ill at 16—30 weeks of gestation. The comparison group (group 3) consisted of 20 pregnant women with bronchial asthma without acute inflammatory diseases during gestation. General clinical examination, extended study of the hemostasis system, hormones of fetoplacental complex and interferon status, acid-base state of capillary blood, saturation, ultrasound and Doppler parameters in dynamics were investigated. Results. It was shown that exacerbation of bronchial asthma during pregnancy was significantly more frequent in the main groups: group 1 — in 70%, group 2 — in 53.3%, group 3 — in 30%. This correlated with the frequency of obstetric and perinatal complications. In Group 1, the Apgar score at birth in 43.3% of newborns was less than 8 points, which was 2.6 times more frequent than in Group 2. Fetal growth retardation in group 1 was diagnosed in 30% of children, which was probably associated with the formation of PI of infectious genesis at an earlier gestational age than in group 2. Conclusion. The obtained results indicate a negative effect of acute respiratory infection on the course of pregnancy in patients with respiratory diseases regardless of the severity of acute respiratory infection. This requires clarification of pathogenetic mechanisms of development of these complications and optimization of management of this contingent of patients.

7 October 2024 in V.F.Snegirev Archives of Obstetrics and Gynecology
Verified
Journal Article
Open access
APAlexander A. Popov
Alexander A. Popov
MOMaiia R. Ovsiannikova
Maiia R. Ovsiannikova
JSJulia I. Sopova
Julia I. Sopova
AFAnton A. Fedorov
Anton A. Fedorov
VTVlada V. Troshina
Vlada V. Troshina
ОРОвсянникова Майя Руслановна
Овсянникова Майя Руслановна
BACKGROUND: Ethanol sclerotherapy is an effective and a safe surgical treatment method for ovarian endometrioma (OMA). Destruction with 95% ethanol solution of the capsule allows minimal impact on the ovarian reserve. However, this method should be thoroughly evaluated for the possibility to be used more frequently in practice. AIM: To determine the indications for the use of transvaginal sclerotherapy in surgical treatment of OMA. MATERIAL AND METHODS: Between October 2021 and October 2023, 17 patients with OMA were operated at the Moscow Regional Research Institute of Obstetrics and Gynecology, with sclerotherapy performed by transvaginal access. Clinical manifestations included pelvic pain (76.4%), dysmenorrhea (82.3%), dyspareunia (47.0%), bowel symptoms (35.3%), polymenorrhea (47.0%), and infertility (64.7%). Eleven (64.7%) of the patients had been previously operated because of ОМА. RESULTS: Postoperative anti-Mullerian hormone (AMH) levels were slightly reduced (mean difference before and after the surgery was 0.47 ng/ml). The mean antral follicle count in the both ovaries were 10.8 before surgery and 8.6 after surgery. The volume of the ovary decreased from 2 to 6 times after sclerotherapy of the endometrioma. Symptoms recurred in four women. Six (35.2%) recurrences of endometrioma were noted with ultrasound control after 3, 6, and 12 months postoperatively. Endometrioid detritus in the cyst capsule was not detected in 64.8% of cases. CONCLUSION: Preliminary results indicates the use of sclerotherapy by transvaginal access with ultrasound control for the treatment of endometriomas in women of reproductive age and patients planning pregnancy by ART with any level of ovarian reserve and recurrent, previously histologically confirmed, symptomatic endometriomas in women of reproductive age with no plans for pregnancy presently with a reduced ovarian reserve (AMH 1.2 ng/ml) and with any level of ovarian reserve but with symptomatic endometrioma in the preserved ovary. Transvaginal access is applicable for symptomatic endometriomas in women who had undergone several operations in the past.